Investment

AgeTech is growing. We speak with an expert

The AgeTech sector is growing fast and the venture capital sector is starting to pay attention; where are the opportunities and risks? New technology seems...

UK doctors told to ignore consumer genetic tests

Royal College of General Practitioners guidance places significant doubt on consumer genetic testing. Consumer interest in genetic testing has grown in popularity in recent years,...

The Longevity Week: Addressing global Longevity

A packed week of multidisciplinary events with a global focus on the Longevity challenge. One year ago, the first Longevity Forum event was held in...

Human Longevity, Inc: $30m injection. Challenges?

Trouble in paradise? Or extra funding for new goals in precision health analytics? The abrupt press announcement on the Human Longevity, Inc. website was one...

Latest articles

Small rooms, big opportunities

Thoughts from the floor of the Investing in the Age of Longevity conference. There’s something I love about being in a small conference room discussing...

New xenotransplantation technology raises $100m

eGenesis race to deliver safe xenotransplantation, is this a welcome reset for xeno technology? The transplantation of animal organs to humans is still a relatively...

Gene editing: “fear and excitement in equal measure”

Top lawyer highlights concerns raised by expected growth in gene editing sector. Earlier this year, a major US financial analyst firm identified Longevity as one...

London addresses the 100 year life. Get ready!

Key summit: Increased global Longevity is a “problem of success”. Today, as part of Longevity Week London 2019, we attended the International Longevity Policy and...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.